Capital Flow Monitor · Sponsors · CIK 2113853
TELYRX HOLDINGS INC.
333 Bay Street, Suite 2400, Toronto, A6, M5H 2T6 · 800-878-1660
Pharmaceuticals · Corporation· inc. ONTARIO, CANADA true 2026
Fit score
—
Offering
$12.6M
Sold
$12.6M
% sold
100.0%
Investors
51
Min investment
$0
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2026-04-20 | D ·current | 506(b) | $12.6M | $12.6M | 100.0% | 51 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed. Other raises are matched by exact name and show amount sold as last reported.
-
Vanessa Slowey — Director / Executive Officer, Toronto, A6
1 other raise
- TelyRx Finco Inc. $12.6M of $12.6M · 100.0%
-
John Eric Cascio — Executive Officer, Toronto, A6
1 other raise
- TelyRx Finco Inc. $12.6M of $12.6M · 100.0%
- Adam Gardner — Executive Officer, Toronto, A6
- Peter Lloyd — Executive Officer, Toronto, A6
- Rafael Jose — Executive Officer, Toronto, A6
- John Eustice — Executive Officer, Toronto, A6
- Robert Sean Foley — Director, Toronto, A6
- Michael Handler — Director, Toronto, A6
- Kenneth Bernard — Director, Toronto, A6
- Andrew Brandt — Director, Toronto, A6
- Ransom Langford — Director, Toronto, A6
Placement agents
- No sales compensation reported — direct raise.
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.